Dr. Sterling would like to reassure his patients that we have exclusively used Mentor implants for primary breast augmentations since 2012 and approximately 1% of our total patients have textured breast implants.
Of the total 573 unique cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reported worldwide, 84% have been attributed to Allergan implants and only 7% have been attributed to Mentor implants. Macro-textured implants (the type of textured implant that Allergan manufactures) represent less than 5% of all breast implants sold in the U.S.
We understand that the most recent news regarding the safety of breast implants and BIA-ALCL may be concerning to our patients. Currently the FDA does not recommend prophylactic removal of breast implants in patients without symptoms.
Dr. Sterling continues to stay updated on this issue as information becomes available. The health and safety of our patients remains our top priority and if you have any questions or concerns, we encourage you to contact the office at 603-518-5450.